UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-QSB

(Mark One)
/ X /    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
         OF THE SECURITIES EXCHANGE ACT OF 1934

         For the quarterly period ended March 31, 2005
OR

/        / TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES
         EXCHANGE ACT OF 1934.

         For the transition period from ________ to ________.


                         Commission file number 0-26059

                               CIRTRAN CORPORATION
                               -------------------
             (Exact name of registrant as specified in its charter)




         Nevada                                          68-0121636
----------------------------                ------------------------------------
(State or other jurisdiction of             (I.R.S. Employer Identification No)
incorporation or organization)

         4125 South 6000 West
         West Valley City, Utah                                 84128
-------------------------------------------------            --------------
(Address of Principal Executive Offices)                       (Zip Code)


(801) 963-5112 (Registrant's telephone number)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  proceeding  12 months and (2) has been subject to such filing  requirements
for the past 90 days. Yes   X   No
                          -----    ----

The number of shares outstanding of the registrant's  common stock as of May 20,
2005: 572,368,569.


Transitional Small Business Disclosure Format (check one): Yes ______   NO  X
                                                                           --



<PAGE>


Table of Contents


                                                                          Page
PART I - FINANCIAL INFORMATION

Item 1.  Condensed Consolidated Financial Statements

         Balance Sheets as of March 31, 2005, (unaudited) and              3
         December 31, 2004

         Statements of Operations for the Three Months ended               4
         March 31, 2005, (unaudited) and 2004 (unaudited)

         Statements of Cash Flows for the Three Months ended               5
         March 31, 2005, (unaudited) and 2004 (unaudited)

         Notes to Condensed Consolidated Financial Statements              8
         (unaudited)

Item 2.  Management's Discussion and Analysis of or Plan of Operation     20

Item 3.  Evaluation of Controls and Procedures                            27

PART II - OTHER INFORMATION

Item 1.  Legal Proceedings                                                28

Item 5.  Other Information                                                30

Item 6   Exhibits                                                         32

Signatures                                                                33





<PAGE>



                                        3

              INDEX TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

         The following financial statements of CirTran Corporation and related
notes thereto are filed as part of this Form 10-QSB:

                                                                            Page

 Condensed Consolidated Balance Sheets as of March 31, 2005,
        (unaudited) and December 31, 2004                                      3

 Condensed Consolidated Statements of Operations for the Three
        Months March 31, 2005, (unaudited)  and 2004                           5

 Condensed Consolidated Statements of Cash Flows for the Three
        Months March 31, 2005, (unaudited)  and 2004                           6

 Notes to Consolidated Financial Statements, (unaudited)                       8



<PAGE>

                      CIRTRAN CORPORATION AND SUBSIDIARIES
                CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)


<TABLE>
<CAPTION>
                                                             March 31,          December 31,
                                                                  2005                  2004
                                                         --------------        --------------

ASSETS
<S>                                                      <C>                   <C>
Current Assets
Cash and cash equivalents                                $     140,610         $      81,101
Trade accounts receivable, net of allowance for doubtful
accounts of $41,560 and $41,143, respectively                1,466,805             1,288,719
Inventory                                                    1,601,841             1,453,754
Other                                                          119,099               153,062
                                                         --------------        --------------
Total Current Assets                                         3,328,355             2,976,636

Property and Equipment, Net                                  2,869,622               840,793

Investment in Securities, at Cost                              300,000               300,000

Other Assets, Net                                               42,520                 8,000

Deposits                                                             -               100,000

Deferred Offering Costs                                         68,000                68,000
                                                         --------------        --------------


Total Assets                                             $   6,608,497         $   4,293,429
                                                         --------------        --------------

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

Current Liabilities
Accounts payable                                         $   1,014,566         $   1,104,392
Accrued liabilities                                          1,122,738             2,066,022
Current maturities of long-term notes payable                2,301,970             1,815,875
Notes payable to stockholders                                        -                18,586
Notes payable to related parties                                     -             1,530,587
                                                         --------------        --------------
Total Current Liabilities                                    4,439,274             6,535,462
                                                         --------------        --------------

Long-Term Notes Payable, Less Current Maturities             1,046,993                     -
                                                         --------------        --------------


Commitments and Contingencies

Stockholders' Equity (Deficit)
Common stock, par value $0.001; authorized 750,000,000
        shares; issued and outstanding shares:
        567,868,569 at March 31, 2005 and
        474,118,569 net of 3,000,000 shares held
        in treasury at no cost at December 31, 2004            567,864               474,114
Additional paid-in capital                                  19,555,696            16,083,455
Accumulated deficit                                        (19,001,330)          (18,799,602)
                                                         --------------        --------------
Total Stockholders' Equity (Deficit)                         1,122,230            (2,242,033)
                                                         --------------        --------------
Total Liabilities and Stockholders' Equity (Deficit)     $   6,608,497         $   4,293,429
                                                         --------------        --------------
</TABLE>



                 The accompanying notes are an integral part of
                          these financial statements.

                                       4

<PAGE>


                      CIRTRAN CORPORATION AND SUBSIDIARIES
           CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)



<TABLE>
<CAPTION>

For the Three Months Ended March 31,                   2005            2004
                                                ------------    ------------

<S>                                             <C>             <C>
Net Sales                                       $ 2,920,465     $   645,612
Cost of Sales                                    (1,949,773)       (433,759)
                                                ------------    ------------

Gross Profit                                        970,692         211,853
                                                ------------    ------------

Operating Expenses
Selling, general and administrative expenses        959,891         545,068
Non-cash employee compensation expense               69,000          33,750
                                                ------------    ------------
Total Operating Expenses                          1,028,891         578,818
                                                ------------    ------------

Loss From Operations                                (58,199)       (366,965)
                                                ------------    ------------

Other Income (Expense)
Interest                                           (143,770)       (156,562)
Other, net                                              241             (96)
Gain on forgiveness of debt                               -          79,036
                                                ------------    ------------
Total Other Expense, Net                           (143,529)        (77,622)
                                                ------------    ------------

Net Loss                                        $  (201,728)    $  (444,587)
                                                ------------    ------------

Basic and diluted loss per common share         $     (0.00)    $     (0.00)
                                                ------------    ------------
Basic and diluted weighted-average
common shares outstanding                       488,490,792     373,825,900
                                                ------------    ------------
</TABLE>




                 The accompanying notes are an integral part of
                          these financial statements.


                                       5

<PAGE>


                      CIRTRAN CORPORATION AND SUBSIDIARIES
           CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)


<TABLE>
<CAPTION>

For the Three Months Ended March 31,                                                           2005                    2004
                                                                                --------------------    --------------------

Cash flows from operating activities
<S>                                                                             <C>                     <C>
Net loss                                                                        $          (201,728)    $          (444,587)
Adjustments to reconcile net loss to net
cash used in operating activities:
Depreciation and amortization                                                                73,660                  61,769
Amortization of loan premium to interest expense                                             11,057                       -
Provision for loss on trade receivables                                                         417                   2,305
Gain on forgiveness of debt                                                                       -                 (79,036)
Non-cash compensation expense                                                                69,000                  33,750
Loan costs and fees in lieu of interest on notes payable                                     61,500                  76,500
Options issued to attorneys and developers for services                                      21,526                  93,701
Changes in assets and liabilities:
Trade accounts receivable                                                                  (119,299)               (189,019)
Inventories                                                                                (148,087)               (235,725)
Prepaid expenses and other assets                                                            (1,836)                 (6,165)
Accounts payable                                                                           (108,800)                 36,245
Accrued liabilities                                                                         (43,111)                253,187
                                                                                --------------------    --------------------

Total adjustments                                                                          (183,973)                 47,512
                                                                                --------------------    --------------------

Net cash used in operating activities                                                      (385,701)               (397,075)
                                                                                --------------------    --------------------

Cash flows from investing activities
Cash acquired with PFE acquisition                                                           39,331                       -
Purchase of property and equipment                                                         (230,771)                (19,505)
                                                                                --------------------    --------------------

Net cash used in investing activities                                                      (191,440)                (19,505)
                                                                                --------------------    --------------------

Cash flows from financing activities
Change in checks written in excess of cash in bank                                                -                  (9,623)
Proceeds from notes payable to stockholders                                                   4,414                   5,748
Payments on notes payable to stockholders                                                         -                 (30,500)
Proceeds from notes payable, net of cash paid for offering costs                            503,500               1,363,500
Principal payments on notes payable                                                               -                (179,619)
Proceeds from notes payable to related parties                                               95,586                 451,223
Payment on notes payable to related parties                                                       -              (1,185,141)
Proceeds from exercise of options and warrants to purchase
common stock                                                                                 33,000                  35,000
Exercise of options issued to attorneys and consultants
for services                                                                                    150                     300
                                                                                --------------------    --------------------

Net cash provided by financing activities                                                   636,650                 450,888
                                                                                --------------------    --------------------

Net increase in cash and cash equivalents                                                    59,509                  34,308

Cash and cash equivalents at beginning of period                                             81,101                  54,135
                                                                                --------------------    --------------------

Cash and cash equivalents at end of period                                      $        140,610        $          88,443
                                                                                --------------------    --------------------
</TABLE>



                 The accompanying notes are an integral part of
                          these financial statements.

                                       6

<PAGE>


                      CIRTRAN CORPORATION AND SUBSIDIARIES
     CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (CONTINUED)

<TABLE>
<CAPTION>

For the Three Months Ended March 31,                                                           2005                    2004
                                                                                --------------------    --------------------
Supplemental disclosure of cash flow information

<S>                                                                             <C>                     <C>
Cash paid during the period for interest                                        $                 -     $            67,292

Noncash investing and financing activities

Notes issued for accounts payable and capital lease obligations                 $                 -     $           503,679
Acquisition of PFE Properties, LLC for stock and assumption
  of mortgage loan                                                              $         1,868,974     $                 -
Common stock issued for settlement of notes payable
  and accrued interest                                                          $         2,148,913     $            30,000
Common stock issuance in which proceeds were retained
  as payment of notes payable                                                   $                 -     $           650,000
Transfer of deposit to property and equipment                                   $           100,000     $                 -
Common stock issued for accrued rent and interest                               $           411,402     $                 -
Accrued interest converted to notes payable                                     $                 -     $             9,160
Stock options exercised for settlement of accrued interest
and accrued compensation                                                        $            59,000     $            40,000
Stock options exercised for settlement of notes payable
to stockholders                                                                 $            23,000     $                 -
Note issued for settlement of notes payable and accrued
interest                                                                        $                 -     $           323,842
Fees withheld from notes payable for Equity Line Agreement                      $                 -     $            26,000
Deferred offering costs withheld from notes payable proceeds                    $                 -     $            60,000
</TABLE>



                 The accompanying notes are an integral part of
                          these financial statements.

                                       7


<PAGE>


                      CIRTRAN CORPORATION AND SUBSIDIARIES
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                  (UNAUDITED)

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Condensed Financial Statements -- The accompanying unaudited condensed
consolidated financial statements include the accounts of CirTran Corporation
and its subsidiaries (the "Company"). These financial statements are condensed
and, therefore, do not include all disclosures normally required by accounting
principles generally accepted in the United States of America. These statements
should be read in conjunction with the Company's annual financial statements
included in the Company's Annual Report on Form 10-KSB. In particular, the
Company's significant accounting principles were presented as Note 1 to the
consolidated financial statements in that Report. In the opinion of management,
all adjustments necessary for a fair presentation have been included in the
accompanying condensed consolidated financial statements and consist of only
normal recurring adjustments. The results of operations presented in the
accompanying condensed consolidated financial statements for the three months
ended March 31, 2005, are not necessarily indicative of the results that may be
expected for the full year ending December 31, 2005.

Principles of Consolidation -- On March 31, 2005, Cirtran Corporation acquired a
100% ownership interest in PFE Properties, LLC (see Note 3).

The condensed consolidated financial statements include the accounts of CirTran
Corporation, and its wholly owned subsidiaries, Racore Technology Corporation
and CirTran-Asia Inc. The accounts of PFE Properties, LLC have been included as
of March 31, 2005. All significant intercompany transactions have been
eliminated in consolidation.

Stock-Based Compensation -- At March 31, 2005, the Company had one stock-based
employee compensation plan, which is described more fully in Note 9. The Company
accounts for the plan under Accounting Principles Board Opinion No. 25,
Accounting for Stock Issued to Employees, ("APB 25") and related
interpretations. During the three months ended March 31, 2005 and 2004, the
Company recognized compensation expense relating to stock options and warrants
of $69,000 and $33,750, respectively. The following table illustrates the effect
on net loss and basic and diluted loss per common share as if the Company had
applied the fair value recognition provisions of Financial Accounting Standards
Board ("FASB") Statement No. 123, Accounting for Stock-Based Compensation, to
stock-based employee compensation:

<TABLE>
<CAPTION>
Three Months Ended March 31,                                                2005                    2004
                                                                    ----------------------   --------------------
<S>                                                                 <C>                      <C>
Net loss, as reported                                               $            (201,728)   $          (444,587)
Add:  Stock-based  employee compensation expense
included in net loss                                                               69,000                 33,750
Deduct:  Total stock-based employee compensation
expense determined under fair value based
method for all awards                                                            (138,248)              (135,473)
                                                                    ----------------------   --------------------

Pro forma net loss                                                  $            (270,976)   $          (546,310)
                                                                    ----------------------   --------------------

Basic and diluted loss per common share as reported                 $               (0.00)   $             (0.00)
                                                                    ----------------------   --------------------

Basic and diluted loss per common share pro forma                   $               (0.00)   $             (0.00)
                                                                    ----------------------   --------------------
</TABLE>


                                       8
<PAGE>

                      CIRTRAN CORPORATION AND SUBSIDIARIES
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                  (UNAUDITED)


Patents -- Legal fees and other direct costs incurred in obtaining patents in
the United States and other countries are capitalized. Patents costs are
amortized over the estimated useful life of the patent. During the three months
ended March 31, 2005, the Company capitalized $35,799 in patent related legal
costs. Amortization expense was $1,279 during the three months ended March 31,
2005.

The realization of patents and other long-lived assets is evaluated periodically
when events or circumstances indicate a possible inability to recover the
carrying amount. An impairment loss is recognized for the excess of the carrying
amount over the fair value of the asset or the group of assets. Fair value is
determined based on expected discounted net future cash flows. The analysis
necessarily involves significant management judgement to evaluate the capacity
of an asset to perform within projections. As required, an evaluation of
impairment was made on the patents as of March 31, 2005. No indicators of
impairment were noted.

NOTE 2 - REALIZATION OF ASSETS

The accompanying consolidated financial statements have been prepared in
conformity with accounting principles generally accepted in the United States of
America, which contemplate continuation of the Company as a going concern.
However, the Company sustained losses of $201,728 and $658,322 for the three
months ended March 31, 2005, and the year ended December 31, 2004, respectively.
As of March 31, 2005, and December 31, 2004, the Company had an accumulated
deficit of $19,001,330 and $18,799,602, respectively, and a total stockholders'
equity (deficit) of $1,122,230 and $(2,242,033), respectively. The Company also
had negative working capital of $1,110,919 and $3,558,826 as of March 31, 2005,
and December 31, 2004, respectively. In addition, the Company used, rather than
provided, cash in its operations in the amounts of $385,701 and $1,680,054 for
the three months ended March 31, 2005, and the year ended December 31, 2004,
respectively. These conditions raise substantial doubt about the Company's
ability to continue as a going concern.

In addition, the Company is a defendant in numerous legal actions (see Note 6).
These matters may have a material impact on the Company's financial position,
although no assurance can be given regarding the effect of these matters in the
future.

In view of the matters described in the preceding paragraphs, recoverability of
a major portion of the recorded asset amounts shown in the accompanying
consolidated balance sheets is dependent upon continued operations of the
Company, which in turn is dependent upon the Company's ability to meet its
financing requirements on a continuing basis, to maintain or replace present
financing, to acquire additional capital from investors, and to succeed in its
future operations. The financial statements do not include any adjustments
relating to the recoverability and classification of recorded asset amounts or
amounts and classification of liabilities that might be necessary should the
Company be unable to continue in existence.

The Company's plans include working with vendors to convert trade payables into
long-term notes payable and common stock, and to cure defaults with lenders
through forbearance agreements that the Company will be able to service. As
discussed in Note 8, the Company has entered into an equity line of credit
agreement and a standby equity distribution agreement with a private investor.
Realization of additional proceeds under the agreements is not assured.


                                       9
<PAGE>
                      CIRTRAN CORPORATION AND SUBSIDIARIES
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                  (UNAUDITED)


NOTE 3 - ACQUISITION OF PFE PROPERTIES, LLC

On March 31, 2005, the Company purchased a 100% interest in PFE Properties LLC
(PFE). PFE was previously owned by a relative of the President and CEO. PFE owns
the land and building in which the Company's manufacturing facilities and
administrative offices are located. The liabilities of PFE on the date of
acquisition include a mortgage note payable of $1,050,000, secured by the
building. The Company acquired PFE by issuing 20,000,000 shares of the Company's
restricted common stock with a fair value of $800,000 on the date of acquisition
and assuming the mortgage note payable of $1,050,000 and accounts payable of
$18,974. The results of operations for PFE have been included for the day of
March 31, 2005. The additional $800,000 for the purchase of PFE was allocated
between the land and building value.

The balance sheet of PFE as of March 31, 2005 is presented as follows:

Current Assets                   $                   98,535

Property and Equipment                            1,770,439

                                 ---------------------------
  Total Assets Acquired                           1,868,974
                                 ---------------------------

Accounts Payable                                     18,974

Mortgage Note Payable                             1,050,000

                                 ---------------------------
  Total Liabilities Assumed                       1,068,974
                                 ---------------------------

  Net Assets Acquired            $                  800,000
                                 ===========================



The pro forma information is presented as if the Company had acquired PFE on
January 1, 2004, as follows:

<TABLE>
<CAPTION>
                                                                                                  For the Three
                                                             For the Year Ended                    Months Ended
                                                              December 31, 2004                  March 31, 2005
                                                     ---------------------------     ---------------------------
                                                                     (Pro Forma)                     (Pro Forma)

<S>                                                  <C>                             <C>
Net Sales                                            $                8,862,715      $                2,920,465

Net Loss                                             $                 (613,378)     $                 (189,714)

Basic and Diluted Loss per Common Share                                   (0.00)                          (0.00)

Basic and Diluted Weighted-Average
  Common Shares Oustanding                                          471,620,617                     490,490,792
</TABLE>


NOTE 4 - INVESTMENT IN SECURITIES AT COST

On April 13, 2004, the Company entered into a stock purchase agreement with an
unrelated party under which the Company purchased 400,000 shares of the
investee's Series B Preferred Stock (the "Preferred Shares") for an aggregate
purchase price of $300,000 cash. This purchase was made at fair value. The
Preferred Shares are convertible, at the Company's option, into an equivalent
number of shares of investee common stock, subject to adjustment. The Preferred
Shares are not redeemable by the investee. As a holder of the Preferred Shares,
the Company has the right to vote the number of shares of investee common stock
into which the Preferred Shares are convertible at the time of the vote. The
investment represents less than a 5% interest in the investee. The investment
does not have a readily determinable fair value and is stated at historical
cost, less an allowance for impairment when circumstances indicate an investment


                                       10
<PAGE>


                      CIRTRAN CORPORATION AND SUBSIDIARIES
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                  (UNAUDITED)

has been impaired. The Company periodically evaluates its investments as to
whether events and circumstances have occurred which indicate possible
impairment. No indicators of impairment were noted for the three months ended
March 31, 2005.

Separate from the purchase of the Preferred Shares, the Company and the investee
also entered into a Preferred Manufacturing Agreement. Under this agreement, the
Company will perform exclusive "turn-key" manufacturing services handling most
of the investee's manufacturing operations from material procurement to complete
finished box-build of all of investee products. The initial term of the
agreement is three years, continuing month to month thereafter unless terminated
by either party. Sales under this agreement totaled $2,429 and $538,233 for the
periods ended March 31, 2005, and December 31, 2004, respectively.

NOTE 5 - RELATED PARTY TRANSACTIONS

Notes Payable to Stockholder -- The Company had amounts due to stockholders from
three separate notes. The balance due to stockholders at March 31, 2005 and
December 31, 2004, was zero and $18,586, respectively. Notes were settled during
the three months ended March 31, 2005 by the exercise of stock options for
$23,000.

Notes Payable to Related Party -- During 2002, the Company entered into a verbal
bridge loan agreement with Abacas Ventures, Inc. (Abacas). This agreement allows
the Company to request funds from Abacas to finance the build-up of inventory
relating to specific sales. The loan bears interest at 24% and is payable on
demand. There are no required monthly payments. During the three months ended
March 31, 2005, and the year ended December 31, 2004, the Company was advanced
$95,586 and $3,128,281, respectively, and made cash payments of zero and
$3,025,149, respectively.

During the three months ended March 31, 2005, the Company issued 51,250,000
shares of the Company's restricted common stock for payment of $2,055,944 in
principal and accrued interest on the note. Because Abacas is a related party,
no gain or loss on forgiveness of debt was recognized.

The total principal amount owed to Abacas between the note payable and the
bridge loan was zero and $1,530,587 as of March 31, 2005, and December 31, 2004,
respectively. The total accrued interest owed to Abacas between the note payable
and the bridge loan was zero and $430,828 as of March 31, 2005, and December 31,
2004, respectively, and is included in accrued liabilities.

NOTE 6 - COMMITMENTS AND CONTINGENCIES

Settlement of Litigation -- During January 2002, the Company settled a lawsuit
that had alleged a breach of facilities sublease agreement involving facilities
located in Colorado. The Company's liability in this action was originally
estimated to range up to $2.5 million. The Company had filed a counter suit in
the same court for an amount exceeding $500,000 for missing equipment.

Effective January 18, 2002, the Company entered into a settlement agreement
which required the Company to pay the plaintiff the sum of $250,000. Of this
amount, $25,000 was paid upon execution of the settlement, and the balance,
together with interest at 8% per annum, was payable by July 18, 2002. As
security for payment of the balance, the Company executed and delivered to the
plaintiff a Confession of Judgment and also issued 3,000,000 shares of common
stock, which were held in escrow and were treated as treasury
stock recorded at no cost. The fair value of the 3,000,000 shares was less than


                                       11
<PAGE>

                      CIRTRAN CORPORATION AND SUBSIDIARIES
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                  (UNAUDITED)


the carrying amount of the note payable. Because 75 percent of the balance had
not been paid by May 18, 2002, the Company was required to prepare and file with
the Securities & Exchange Commission, at its own expense, a registration
statement with respect to the escrowed shares.

As of March 31, 2005, the Company was in default of its obligations under the
settlement agreement and the total payment due thereunder had not been made. A
registration statement with respect to the escrowed shares was not filed and the
Company did not replace the escrowed shares with registered, free-trading shares
as per the terms of the agreement. The plaintiff filed a Confession of Judgment
and proceeded with execution thereon. The shares in escrow were released and
issued as partial settlement of $92,969 on the note payable outstanding.

In connection with a separate sublease agreement of these facilities, the
Company received a settlement from the sublessee during May 2002, in the amount
of $152,500, which has been recorded as other income. The Company did not
receive cash from this settlement, but certain obligations of the Company were
paid directly. $109,125 of the principal balance of the note related to the
settlement mentioned above was paid. Also, $7,000 was paid to the Company's
legal counsel as a retainer for future services. The remaining $36,375 was paid
to the above mentioned plaintiff as a settlement of rent expense.

During September 2002, the plaintiff filed a claim that the $109,125 portion of
the payment was to be applied as additional rent expense rather than a principal
payment on the note payable. The Company estimates that the probability of the
$109,125 being considered additional rent expense is remote and disputes the
claim. The Company intends to vigorously defend the action.

Litigation - During 2003 and 2004, an investment firm filed suits in the U.S.
District Court for the District of Utah seeking finder's fees consisting of
common stock valued at $1,750,000 for allegedly introducing the Company to the
Equity Line Investor (See Note 8). The case was previously dismissed in a New
York court. The Company estimates that the risk of loss is remote; therefore no
accrual has been made.

Various vendors have notified the Company that they believe they have claims
against the Company totaling $147,592. None of these vendors have filed lawsuits
in relation to these claims. The Company has accrued the entire amount of these
claims, and they are included in accounts payable.

In addition, various vendors have notified the Company that they believe they
have claims against the Company totaling $159,308. The Company has determined
the probability of realizing any loss is remote. The Company has made no accrual
for these claims and is currently in the process of negotiating the dismissal of
these claims with the various vendors.

The Company is also the defendant in numerous immaterial legal actions primarily
resulting from nonpayment of vendors for goods and services received. The
Company has accrued the payables and is currently in the process of negotiating
settlements with these vendors.

Registration Rights - In connection with the conversion of certain debt to
equity during 2000, the Company granted the holders of 5,281,050 shares of
common stock the right to include 50% of the common stock of the holders in any
registration of common stock of the Company, under the Securities Act for offer
to sell to the public (subject to certain exceptions). The Company has also
agreed to keep any filed registration statement effective for a period of 180
days at its own expense.



                                       12
<PAGE>

                      CIRTRAN CORPORATION AND SUBSIDIARIES
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                  (UNAUDITED)


Additionally, in connection with the Company's entering into an Equity Line of
Credit Agreement (described in Note 8), the Company granted to the equity line
investor (the "Equity Line Investor") registration rights, in connection with
which the Company is required to file a registration statement covering the
resale of shares put to the Equity Line Investor under the equity line. The
Company is also required to keep the registration statement effective until two
years following the date of the last advance under the equity line.

Also, in connection with the Company's entering into a standby equity
distribution agreement (described in Note 7), the Company granted to the
investor registration rights, in connection with which the Company is required
to file a registration statement covering the resale of shares put to the
investor under the standby equity distribution agreement. The Company is also
required to keep the registration statement effective until two years following
the date of the last advance under the standby equity distribution agreement.
The Company has not yet had such registration statement declared effective by
the Securities and Exchange Commission.

Accrued Payroll Tax Liabilities -- In November 2004, the Internal Revenue
Service (IRS) accepted the Company's Amended Offer in Compromise (Offer) to
settle delinquent payroll taxes, interest and penalties. The acceptance of the
Offer required the Company to pay $500,000 by February 3, 2005. The Company made
the required payment on February 2, 2005. Additionally, the Offer requires the
Company to remain current in its payment of taxes for 5 years, and may not claim
any net operating losses for the years 2001 through 2015, or until the Company
pays taxes in an amount equal to the taxes waived by the offer in compromise.
The outstanding balance of delinquent payroll taxes, interest and penalties
was $1,955,767 on the settlement date. The future cash payments specified by the
Offer, including interest and principal, were less than the carrying amount of
the payable; therefore the Company reduced the carrying amount of the liability
to the total future cash payments of $500,000 and recorded a gain of $1,455,767
during the year ended December 31, 2004.

Further, the Utah State Tax Commission has entered into an agreement to allow
the Company to pay the liability owing to the State of Utah in equal monthly
installments of $4,000 over a two-year period running through December 2005.
Through March 2005, the Company had made the required payments. The balance owed
to the State of Utah as of March 31, 2005, and December 31, 2004, was $167,627
and $223,660, respectively, including penalties and interest.

Manufacturing Agreement -- On June 10, 2004, the Company entered into an
exclusive manufacturing agreement with certain Developers. Under the terms of
the agreement, the Company, through its wholly-owned subsidiary CirTran-Asia,
has the exclusive right to manufacture the certain products developed by the
Developers or any of their affiliates. The Developers will continue to provide
marketing and consulting services related to the products under the agreement.
Should the Developers terminate the agreement early, they must pay the Company
$150,000. Revenue is recognized when products are shipped. Title passes to the
customer or independent sales representative at the time of shipment.

In connection with this agreement the Company has agreed to issue options to
purchase 1,500,000 shares common stock to the Developers upon the sale, shipment
and payment for 200,000 units of a fitness product. In addition, the Company
agreed to issue options to purchase 300,000 shares of common stock to the
Developers for each multiple of 100,000 units of the fitness product sold in
excess of the initial 200,000 units within twenty-four months of the agreement
(June 2004). The options will be exercisable at $0.06 per share, vest on the
grant date and expire one year after issuance. As of March 31, 2005, the Company


                                       13
<PAGE>

                      CIRTRAN CORPORATION AND SUBSIDIARIES
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                  (UNAUDITED)


had sold, shipped and received payment for, 229,602 units of the fitness
product. In January 2005, the Company issued 1,500,000 options under the terms
of the agreement. See Note 9.

In connection with the above manufacturing agreement, the Company agreed to
issue various options to purchase shares of common stock to the Developers upon
the sale, shipment, and payment of certain quantities of additional the
products. In addition, the Company agreed to issue additional options to
purchase common stock to the developers for each multiple of units sold in
excess of the initial units within the first twenty-four months of the
agreements. The schedule of units and potential options that will be issued
follows:

<TABLE>
<CAPTION>
                                                           Options        Each Multiple of          Options for
                                   Initial             for Initial             Units above        Each Multiple
      Product                        Units              Units Sold           Initial Units             of Units
-------------------------- ----------------------- -------------------- ----------------------- ----------------
<S>      <C>               <C>                     <C>                  <C>                     <C>
         1                         500,000                 500,000                 200,000             200,000
         2                          25,000                 500,000                  15,000             100,000
         3                         100,000                 500,000                  50,000             100,000
         4                         300,000               1,000,000                 100,000             200,000
         5                         200,000                 250,000                 100,000             100,000
         6                         200,000                 500,000                 100,000             100,000
</TABLE>


As of March 31, 2005, the Company had not sold, shipped and received payment for
enough units to require the issuance of options related to the additional
products under these agreements. Because the Developers must provide future
services for the options to vest, the options are treated as unissued for
accounting purposes. The cost of these options will be recognized when the
options are earned.

NOTE 7 - NOTES PAYABLE

Notes Payable to Equity Line Investor -- As of December 31, 2004, the Company
owed $1.7 million to Cornell Capital Partners, LP, pursuant to an unsecured
promissory note. The note was repayable over 193 days and is past due as of
March 31, 2005. The note states that if the Company does not repay the note when
due, a default interest rate of 24% will apply to the unpaid balance. The
Company recorded accrued interest of $105,074 on the note.

In January 2005, the Company entered into an additional promissory note with
Cornell for $565,000. The Company received proceeds of $503,500, net of loan
costs of $61,500. The terms of the note include a 9% premium or $50,850,
resulting in a total note payable of $615,850. The premium will be amortized to
interest expense over the life of the loan. The terms of the loan state that
interest only payments will be made for the first six months. The Company will
repay the principal, interest, and premium over the next six months. The loan is
due January 2006. The Company amortized $11,057 of the premium as interest
expense for the three months ended March 31, 2005. The note payable balance as
of March 31, 2005, was $576,057, net of a premium of $39,793.

Mortgage Note Payable -- In conjuction with the acquisition of PFE, the Company
assumed a mortgage note payable for $1,050,000. The note bears interest at
12.5%. Interest only payments are required through January 2006. Starting in
February 2006, principal and interest payments will be required based on a


                                       14
<PAGE>

                      CIRTRAN CORPORATION AND SUBSIDIARIES
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                  (UNAUDITED)


twenty-year amortization of the note. The entire balance of principal and unpaid
interest will be due in December 2008.

NOTE 8 - STOCKHOLDERS' EQUITY

Common Stock  Issuances  -- During the three  months  ended March 31, 2005,  the
Company issued  51,250,000  shares of the Company's  restricted common stock for
payment of principal and accrued interest on the note to Abacus. (See Note 4)

During the three months ended March 31, 2005, the Company issued 10,000,000
shares of the Company's restricted common stock for payment of accrued rent and
accrued interest of $411,402. Because the rent was owed to a related party, no
gain or loss on forgiveness of debt was recognized.

During the three months ended March 31, 2005, the Company issued 3,000,000
shares of the Company's restricted common stock as partial payment on a note
payable for $92,969. (See Note 6)

On March 31, 2005, the Company  acquired a 100% interest in PFE Properties,  LLC
for 20,000,000 shares of the Company's restricted common stock. (See Note 3)

Equity Line of Credit Agreement -On November 5, 2002, the Company entered into
an Equity Line of Credit Agreement (the "Equity Line Agreement") with Cornell
Capital Partners, LP, a private investor ("Cornell"). The Company subsequently
terminated the Equity Line Agreement, and on April 8, 2003, the Company entered
into an amended equity line agreement (the "Amended Equity Line Agreement") with
Cornell. Under the Amended Equity Line Agreement, the Company has the right to
draw up to $5,000,000 from Cornell against an equity line of credit (the "Equity
Line"), and to put to Cornell shares of the Company's common stock in lieu of
repayment of the draw. The number of shares to be issued is determined by
dividing the amount of the draw by the lowest closing bid price of our common
stock over the five trading days after the advance notice is tendered. Cornell
is required under the Amended Equity Line Agreement to tender the funds
requested by the Company within two trading days after the five-trading-day
period used to determine the market price.

Standby Equity Distribution Agreement - The Company entered into a Standby
Equity Distribution Agreement dated May 21, 2004, with Cornell. Under the
Agreement, the Company has the right, at its sole discretion, to draw up to $20
million on the standby equity facility (the "SEDA Facility") and put to Cornell
shares of its common stock in lieu of repayment of the draws. The number of
shares to be issued in connection with each draw is determined by dividing the
amount of the draw by the lowest volume-weighted average price of our common
stock during the five consecutive trading days after the advance is sought. The
maximum advance amount is $1,000,000 per advance, with a minimum of seven
trading days between advances. Cornell will retain 5% of each advance as a fee
under the Agreement. The term of the Agreement runs over a period of twenty-four
months after a registration statement related to the Agreement is declared
effective or until the full $20 million has been drawn, whichever comes first.
As of May 20, 2005, the Company had made no draws against the SEDA Facility and
issued no shares in connection with the SEDA Facility.

The Company intends to terminate the Equity Line of Credit Agreement and cease
further draws or issuances of shares in connection with the Equity Line
Agreement when it is able to draw against the SEDA Facility, which will be when


                                       15
<PAGE>

                      CIRTRAN CORPORATION AND SUBSIDIARIES
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                  (UNAUDITED)


the SEC declares effective a registration statement registering resale by
Cornell of shares issued under the SEDA Facility. The SEC has not yet declared
the registration statement effective.

NOTE 9 - STOCK OPTIONS AND WARRANTS

Stock-Based Compensation - The Company accounts for stock options issued to
directors, officers and employees under APB No. 25 and related interpretations.
Under APB 25, compensation expense is recognized if an option's exercise price
on the measurement date is below the fair value of the Company's common stock.
For options that provide for cashless exercise or that have been modified, the
measurement date is considered the date the options are exercised or expire.
Those options are accounted for as variable options with compensation adjusted
each period based on the difference between the market value of the common stock
and the exercise price of the options at the end of the period. The Company
accounts for options and warrants issued to non-employees, including the
developers mentioned in Note 6, at their fair value in accordance with Statement
of Financial Accounting Standards No. 123, "Accounting for Stock-Based
Compensation" ("SFAS 123").

Stock Option Plan - During February 2003, the Company adopted the 2002 Stock
Option Plan (the "2002 Plan") with 25,000,000 shares of common stock reserved
for issuance there under. Also, during November 2003, the Company adopted the
2003 Stock Option Plan (the "2003 Plan") with 35,000,000 shares of common stock
reserved for issuance there under. Also, during December 2004, the Company
adopted the 2004 Stock Option Plan (the "2004 Plan") with 40,000,000 shares of
common stock reserved for issuance there under. The Company's Board of Directors
administers the plans and has discretion in determining the employees,
directors, independent contractors and advisors who receive awards, the type of
awards (stock, incentive stock options or non-qualified stock options) granted,
and the term, vesting, and exercise prices.

Non-Employee Options - During the three months ended March 31, 2005, 1,500,000
previously issued options were exercised by counsel for the company for cash
proceeds of $150.

Employee Options - During the three months ended March 31, 2005, the Company
granted options to purchase 8,000,000 shares of common stock to directors and
employees of the Company pursuant to the 2004 Plan. These options are five year
options that vested on the date of grant. The related exercise prices were
$0.027 per share. The exercise price equaled the fair value of the common shares
at the time these options were granted; therefore, the options had no intrinsic
value. Eight million options were exercised during the three months ended
March 31, 2005, for $33,000 of cash, $69,000 of compensation, $59,000 of accrued
compensation, and $23,000 as payment on a shareholder note payable. The $69,000
of compensation was recorded in conjunction with the cashless exercise of
3,000,000 of the options.

Developer Options - During the three months ended March 31, 2005, the Company
granted options to purchase 1,500,000 shares of common stock to developers as
described in Note 6 at exercise prices of $0.06 per share. The options were all
five-year options and vested on the dates granted. Two of the developers were
employees and together were issued 1,000,000 of the options. The exercise price
equaled the fair value of the common shares at the time these options were
granted therefore the options had no intrinsic value. The fair value of these
options of $42,052 was estimated using the Black-Scholes option pricing model
with the following assumptions: risk free interest rate ranging of 4.00%,
dividend yield of 0.0%, volatility of 302%, and expected average life of .5
years. None of these options were exercised during the three months ended March
31, 2005.



                                       16
<PAGE>

                      CIRTRAN CORPORATION AND SUBSIDIARIES
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                  (UNAUDITED)


The remaining 500,000 developer options were issued to a non-employee under the
terms described above. Because the developer was a non-employee, cost of goods
sold of $21,526 was recorded for the fair value of options issued during the
three months ended March 31, 2005. These options were valued using the
Black-Scholes option pricing model with the following assumptions: risk free
interest rate ranging of 4.00%, dividend yield of 0.0%, volatility of 302%, and
expected average life of .5 years. None of these options were exercised during
the three months ended March 31, 2005.

A total of 12,249,500 employee options and 2,000,500 non-employee options were
outstanding as of March 31, 2005.

A summary of the stock option activity for the three months ended March 31,
2005, is as follows:

                                     Shares               Weighted Average
                                                          Exercise Price
                                   -----------------   --------------------
Outstanding at December 31, 2004         14,250,500                 $ 0.02
Granted                                   9,500,000                 $ 0.03
Exercised                                (9,500,000)                $ 0.02
Cancelled                                         -                      -
                                   -----------------
Outstanding at March 31, 2005            14,250,500                 $ 0.03
                                   =================

Exercisable at March 31, 2005            14,250,500                 $ 0.03
                                   =================


The fair value of stock options was determined at the grant dates using the
Black-Scholes option-pricing model with the following weighted-average
assumptions for the three months ended March 31, 2005:

                                              2004
                                         ----------------
Expected dividend yield                             -
Risk free interest rate                         3.76%
Expected volatility                              282%
Expected life                            $       0.16
Weighted average fair value per share    $       0.02


NOTE 10 -SEGMENT INFORMATION

Segment information has been prepared in accordance with SFAS No. 131,
"Disclosure About Segments of an Enterprise and Related Information." The
Company has three reportable segments: electronics assembly, Ethernet
technology, and contract manufacturing. The electronics assembly segment
manufactures and assembles circuit boards and electronic component cables. The
Ethernet technology segment designs and manufactures Ethernet cards. The
contract manufacturing segment manufactures, either directly or through foreign
subcontractors, certain products under an exclusive manufacturing agreement. The
accounting policies of the segments are consistent with those described in the
summary of significant accounting policies. The Company evaluates performance of
each segment based on earnings or loss from operations. Selected segment
information is as follows:


                                       17
<PAGE>

                      CIRTRAN CORPORATION AND SUBSIDIARIES
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                  (UNAUDITED)


<TABLE>
<CAPTION>
                                         Electronics             Ethernet               Contract
                                           Assembly             Technology            Manufacturing               Total
                                      -------------------   --------------------   --------------------    ---------------------

             March 31, 2005

<S>                                   <C>                   <C>                    <C>                     <C>
Sales to external customers           $          773,013    $            22,608    $         2,124,844     $          2,920,465
Intersegment sales                                     -                      -                      -                        -
Segment income (loss)                           (372,197)               (66,739)               237,208                 (201,728)
Segment assets                                 4,591,074                216,838              1,800,585                6,608,497
Depreciation and amortization                     50,399                    594                 22,667                   73,660

             March 31, 2004

Sales to external customers           $          621,614    $            23,998    $                 -     $            645,612
Intersegment sales                                 8,721                      -                      -                    8,721
Segment loss                                    (383,517)               (61,070)                     -                 (444,587)
Segment assets                                 2,394,885                229,597                      -                2,624,482
Depreciation and amortization                     60,845                    924                      -                   61,769
</TABLE>


<TABLE>
<CAPTION>
                                                                                    March 31,
                                                                -------------------------------------------
                  Sales                                                2005                   2004
                                                                --------------------   --------------------

<S>                                                             <C>                    <C>
Total sales for reportable segments                             $         2,920,465    $           654,333
Elimination of intersegment sales                                                 -                 (8,721)
                                                                --------------------   --------------------

Consolidated net sales                                          $         2,920,465    $           645,612
                                                                --------------------   --------------------
</TABLE>

<TABLE>
<CAPTION>
                                                                                     March 31,
                                                                -------------------------------------------
              Total Assets                                             2005                   2004
                                                                --------------------   --------------------

<S>                                                             <C>                    <C>
Total assets for reportable segments                            $         6,608,497    $         2,624,482
Adjustment for intersegment amounts                                               -                      -
                                                                --------------------   --------------------

Consolidated total assets                                       $         6,608,497    $         2,624,482
                                                                --------------------   --------------------
</TABLE>



NOTE 11 - SUBSEQUENT EVENTS

Stock Options - On April 11, 2005 the Company granted options to purchase
3,000,000 and 2,000,000 shares of the Company's common stock to directors and
employees of the Company, respectively. These options were five-year options
that vested immediately and had an exercise price of $0.027 per share. The
exercise price of the options equaled the fair value of the common shares on the
date of grant therefore the options had no intrinsic value. The Company
estimated the fair value of the options at the grant date using the
Black-Scholes option-pricing model. The following assumptions were used in the
Black-Scholes model to determine the fair value of the options to purchase a
share of common stock of $0.01: risk-free interest rate of 4.13%, dividend yield
of 0 percent, volatility of 271%, and expected lives of 0.10 years.


                                       18
<PAGE>

                      CIRTRAN CORPORATION AND SUBSIDIARIES
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                  (UNAUDITED)


During April 2005, directors exercised options to purchase 3,000,000 shares of
commons stock with a weighted average exercise price of $0.03 per share. These
options were exercised for consideration consisting of $81,000 of accrued
compensation.

On April 11, 2005, the Company granted options to purchase 1,500,000 shares of
common stock to counsel for the Company with an exercise price of $0.0001 per
share. The options were five year options and vested on the date granted. Legal
expense of $40,351 was recorded for the fair value of options issued. These
options were valued using the Black-Scholes option pricing model with the
following assumptions: risk free interest rate ranging of 4.13%, dividend yield
of 0.0%, volatility of 271%, and expected average life of .10 years. These
options were exercised in April 2005 for proceeds of $150.


                                       19
<PAGE>




ITEM 2.           MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATIONS

This discussion should be read in conjunction with Managements' Discussion and
Analysis of Financial Condition and Results of Operations included in our Annual
Report on Form 10-KSB for the year ended December 31, 2004.

Overview

We provide a mixture of high and medium size volume turnkey manufacturing
services using surface mount technology, ball-grid array assembly,
pin-through-hole and custom injection molded cabling for leading electronics
OEMs in the communications, networking, peripherals, gaming, law enforcement,
consumer products, telecommunications, automotive, medical, and semiconductor
industries. Our services include pre-manufacturing, manufacturing and
post-manufacturing services. Through our subsidiary, Racore Technology
Corporation, we design and manufacture Ethernet technology products. Our goal is
to offer customers the significant competitive advantages that can be obtained
from manufacture outsourcing, such as access to advanced manufacturing
technologies, shortened product time-to-market, reduced cost of production, more
effective asset utilization, improved inventory management, and increased
purchasing power.

During 2004, we established a new division, CirTran-Asia, Inc, which has
contributed to a large portion of the increase in revenue for the year ended
December 31, 2004, and the three months ended March 31, 2005. This new division,
is our Asian-based, wholly owned subsidiary of CirTran Corporation and provides
a myriad of manufacturing services to the direct response and retail consumer
markets. Our experience and expertise in manufacturing enables CirTran-Asia to
enter a project at any phase: engineering and design, product development and
prototyping, tooling, and high-volume manufacturing.

CirTran has established a dedicated satellite office for CirTran-Asia, and has
retained Mr. Charles Ho to lead the new division. Having proven the value and
reliability of its core products, CirTran Corporation has chosen to expand into
previously untapped product lines. CirTran-Asia will pursue manufacturing
relationships beyond printed circuit board assemblies, cables, harnesses and
injection molding systems by establishing complete "box-build" or "turn-key"
relationships in the electronics, retail, and direct consumer markets.

We have been preparing since 2003 for this strategic move into the Asian market.
Management anticipates that this new division will elevate CirTran to an
international contract manufacturer status for multiple products in a wide
variety of industries, and will, in short order, allow us to target large-scale
contracts. We anticipate that our new clients will be leading manufacturing and
marketing firms in the retail and direct consumer markets.

Information relating to recent developments in our increasing line of fitness
products is as follows:

On June 7, 2004, we announced that CirTran-Asia had received an initial purchase
order on May 26, 2004, relating to the manufacture of 80,000 abdominal fitness
machines. This order was the first order placed with CirTran-Asia under the
exclusive manufacturing agreement. Subsequently, on June 14, 2004, we received
another order for 80,000 units of the abdominal fitness machines, which was
announced on June 16, 2004, through a separate press release. Since these
announcements, CirTran-Asia has manufactured, shipped, and received payments of
approximately $5,546,000. On August 13, 2004, we also announced that on August
11, 2004 we had received new orders for Wal-Mart. The company shipped to


                                       20
<PAGE>

Wal-Mart the complete order of abdominal fitness machines and received payments
of approximately $400,000 to date. The units were distributed to Wal-Mart stores
throughout Canada.

On August 11, 2004, we announced that CirTran-Asia received a purchase order on
August 10, 2004 relating to the manufacture of a household cooking appliance for
hot dogs and sausages. Since these announcements, CirTran-Asia has manufactured,
and shipped units, and received payments of approximately $437,000.

On September 9, 2004, we announced that on September 6, 2004, CirTran-Asia had
been awarded the rights to manufacture a new abdominal fitness machine under the
exclusive manufacturing agreement. This new product is another type of abdominal
fitness machine. We are still awaiting production orders to begin manufacturing
and shipping.

On September 10, 2004, we announced that on September 7, 2004, CirTran-Asia had
been was awarded the rights to manufacture another type of an abdominal fitness
machine under the exclusive manufacturing agreement. Since this announcement,
CirTran-Asia has manufactured, and shipped units, and received payments of
approximately $720,000.

On September 14, 2004, we announced that on September 7, 2004, we had begun
manufacturing another type of abdominal fitness machine under the exclusive
manufacturing agreement. Since this announcement, CirTran-Asia has manufactured,
and shipped units, and received payments of approximately $390,000.

On September 30, 2004, we announced that on September 23, 2004, CirTran-Asia had
been awarded the rights to manufacture a pilates fitness machine under the
exclusive manufacturing agreement. Since this announcement, CirTran-Asia has
manufactured, and shipped units, and received payments of approximately $85,000.

Information relating to recent developments in new products under development
along with procuring new products for development is as follows:

On January 19, 2005, CirTran Corporation signed an Exclusive Manufacturing
Agreement with a company relating to the manufacture of a hair product in
California. Since these announcements, CirTran-Asia has manufactured and shipped
approximately $1,274,000 worth of units.

On October 1, 2004, we entered into an agreement with Transactional Marketing
Partners, Inc. ("TMP"), for consulting services. Pursuant to the agreement, we
engaged TMP to provide strategic planning and for introduction of new business
to us. Under the agreement, we agreed to pay to TMP a fee of ten percent of the
net proceeds received by us from business brought to us by TMP. The fee is to be
paid within 15 calendar days following the end of the month in which we receive
the net proceeds. Additionally, we agreed to pay $7,500 during each of the first
three months of the term of the agreement, with such payments being viewed as an
advance against the fee to be earned. The advance payments are not refundable,
but will be deducted from fees earned by TMP. The agreement has an initial term
of six months, beginning October 1, 2004, and can be automatically extended for
successive six-month periods unless either party gives written notice at least
30 days prior to the expiration of the term of the agreement of its intent not
to renew. Additionally, we may terminate the agreement at any time by giving 30
days written notice. In March 2005, we extended our agreement to an additional 6
months that will expire in early September 2005. The parties will evaluate the
relationship at that time and decide if there needs to be another extension. To
date the relationship has proven successful resulting in multiple new
manufacturing relationships.

On April 28, 2005, CirTran-Asia announced that it has been awarded a $30 million
contract to be the exclusive manufacturer of a new fitness machine for the


                                       21
<PAGE>

sold-on-TV direct response industry. Since then, we have received orders
totaling approximately $700,000 and expect to complete the shipment before the
end of June 2005.

Significant Accounting Policies

Financial Reporting Release No. 60, which was recently released by the
Securities and Exchange Commission, requires all companies to include a
discussion of critical accounting policies or methods used in the preparation of
financial statements. Note 1 of the Notes to the Financial Statements contained
in our Annual Report on form 10-KSB/A includes a summary of the significant
accounting policies and methods used in the preparation of our Financial
Statements. The following is a brief discussion of the more significant
accounting policies and methods used by us.

Our discussion and analysis of our financial condition and results of operations
is based upon our consolidated financial statements, which have been prepared in
accordance with accounting principles generally accepted in the United States.
These principles require us to make estimates and judgments that affect the
reported amounts of assets, liabilities, revenues and expenses, and related
disclosure of contingent assets and liabilities. We base our estimates on
historical experience and on various other assumptions that are believed to be
reasonable under the circumstances. Estimated amounts may differ under different
assumptions or conditions, and actual results could differ from the estimates.

         Revenue Recognition

Revenue is recognized when products are shipped. Title passes to the customer or
independent sales representative at the time of shipment. Returns for defective
items are repaired and sent back to the customer. Historically, expenses
experienced with such returns have not been significant and have been recognized
as incurred.

         Inventories
Inventories are stated at the lower of average cost or market value. Costs
include labor, material, and overhead costs. Overhead costs are based on
indirect costs allocated among cost of sales, work-in-process inventory, and
finished goods inventory. Indirect overhead costs have been charged to cost of
sales or capitalized as inventory based on management's estimate of the benefit
of indirect manufacturing costs to the manufacturing process.
When there is evidence that the inventory's value is less than original cost,
the inventory is reduced to market value. The Company determines market value on
current resale amounts and whether technological obsolescence exists. The
Company has agreements with most of its customers that require the customer to
purchase inventory items related to their contracts in the event that the
contracts are cancelled. The market value of related inventory is based upon
those agreements. The Company typically orders inventory on a
customer-by-customer basis. In doing so the Company enters into binding
agreements that the customer will purchase any excess inventory after all orders
are complete. Almost 80% of the total inventory is secured by these agreements.

Related Party Transactions

Certain transactions involving Abacas Ventures, Inc., the Saliba Private Annuity
Trust and the Saliba Living Trust are regarded as related party transactions
under FAS 57. Disclosure concerning these transactions is set out in this Item 2


                                       22
<PAGE>

under "Liquidity and Capital Resources - Liquidity and Financing Arrangements,"
and in "Item 5 - Other Information."

Results of Operations - Comparison of Periods Ended March 31, 2005 and 2004

         Sales and Cost of Sales

Net sales increased to $2,920,465 for the three-month period ended March 31,
2005, as compared to $645,612 during the same period in 2004, for an increase of
352.4%. The first quarter sales increase can be attributed to several factors,
including the strengthening of the overall market economy. Industry-wide, we are
seeing more OEMs release larger order commitments with extended time tables. The
second factor directly related to CirTran is our marketing approach. Most
contract manufacturers approach customers on a job-by-job basis. CirTran
approaches customers on a partner basis. We have developed a program where we
can be more effective when we control the material procurement, purchasing, and
final assembly, providing the customer a final quality product delivered on time
and at a lower market cost. Between these new approaches, sales have resulted in
an increase of approximately $150,000 during the three months ended March 31,
2005. The biggest factor contributing to the increase of net sales during the
first quarter was the new division, CirTran-Asia, which has contributed
$2,124,853 of the increase in revenue. CirTran-Asia, yhe Asian-based wholly
owned subsidiary of CirTran Corporation, provides a myriad of manufacturing
services to the direct response and retail consumer markets. Our vast experience
and expertise in manufacturing enables CirTran-Asia to enter a project at any
phase: engineering and design, product development and prototyping, tooling, and
high-volume manufacturing. Cost of sales increased by 349.5%, from $433,759
during the three-month period ended March 31, 2004, to $1,949,773 during the
same period in 2005. The increase in cost of sales is due to the increase in
revenue. Our gross profit margin for the three-month period ended March 31,
2005, was 33.2%, up from 32.8% for the same period in 2004. The increase
insignificant.

         Inventory

We use just-in-time manufacturing, which is a production technique that
minimizes work-in-process inventory and manufacturing cycle time, while enabling
us to deliver products to customers in the quantities and time frame required.
This manufacturing technique requires us to maintain an inventory of component
parts to meet customer orders. Inventory at March 31, 2005, was $1,601,841, as
compared to $1,453,754 at December 31, 2004. The increase in inventory is
required to facilitate the continuing increase in turnkey sales.

         Selling, General and Administrative Expenses

During the quarter ended March 31, 2005, selling, general and administrative
expenses were $959,891 versus $545,068 for the same period in 2004, a 76.1%
increase. The increase was due to expenses related to the CirTran-Asia division,
along with our efforts to aggressively market our products. Selling, general and
administrative expenses as a percentage of sales as of March 31, 2005 were 32.9%
as compared to 84.4% during the same period in 2004. This decrease is due in
part to an increase in sales and better control of expenses.

         Interest Expense

Interest expense for quarter ended March 31, 2005, was $143,770 as compared to
$156,562 for the same period in 2004, a decrease of 8.2%. The decrease is
primarily due to the reduction of various notes payable.

                                       23
<PAGE>

As a result of the above factors, our overall net loss decreased 60.0% to
$201,728 for the quarter ended March 31, 2005, as compared to $444,587 for the
quarter ended March 31, 2004. This decrease was in part attributed to a
substantial increase in sales and better cost controls.

Liquidity and Capital Resources

Our expenses are currently greater than our revenues. We have had a history of
losses, and our accumulated deficit was $19,001,330 at March 31, 2005, and
$18,799,602 at December 31, 2004. Our net loss for the quarter ending March 31,
2005, was $201,728, compared to $444,587 for the quarter ended March 31, 2004.
Our current liabilities exceeded our current assets by $1,110,919 as of March
31, 2005, and $3,558,826 as of December 31, 2004. The decrease was mostly
attributable to settlements of notes payable, decreasing account payables, and
an increase in accounts receivable and inventory. For the three months ended
March 31, 2005 and 2004, we had negative cash flows from operations of $385,701
and $397,075 respectively. For the three months ended March 31, 2005, we have a
slightly improved the cash flow by $11,374, as compared to the three months
ended March 31, 2004.

         Cash

We had cash on hand of $140,610 at March 31, 2005, and $81,101 at December 31,
2004.

Net cash used in operating activities was $385,701 for the three months ended
March 31, 2005. Cash received from customers of $2,742,379 was not sufficient to
offset cash paid to vendors, suppliers, and employees of $3,128,080. The
non-cash charges were for depreciation and amortization of $73,660 and loan
costs and interest paid from loan proceeds of $61,500. Because the Company has
negative cash flows from operations, it must rely on sources of cash other than
customers to support its operations. It is anticipated that various methods of
equity financing will be required to support operations until cash flows from
operations are positive.

Net cash used in investing activities during the three months ended March 31,
2005, consisted of equipment purchases of $230,771 and cash acquired with PFE
acquisition in the amount of $39,331.

Net cash provided by financing activities was $636,650 during the three months
ended March 31, 2005. Principal sources of cash were proceeds of $95,586 from
notes payable to related parties, proceeds from notes payable of $503,500, and
proceeds from the exercise of options to purchase common stock of $33,000.

         Accounts Receivable

At March 31, 2005, we had receivables of $1,466,805, net of a reserve for
doubtful accounts of $41,560, as compared to $1,288,719 at December 31, 2004,
net of a reserve of $41,143. This increase was primarily attributed to sales
having substantially increased in the last month of the first quarter as
compared to the last two months in 2004. The Company has implemented an
aggressive process to collect past due accounts over the past several years. As
such, the receivables that were past due for a period of greater than 45 days as
of March 31, 2005, were less than 5% of total receivables. Individual accounts
are continually monitored for collectibilty. As part of monitoring individual
customer accounts, the Company evaluates the adequacy of its allowance for
doubtful accounts. Since the implementation of the new collection process, very
few accounts have been deemed uncollectible. In addition, the majority of the
increase in accounts receivable as of March 31, 2005, related to sales that
occurred in the last month of the quarter. Therefore they were not deemed
uncollectible.

                                       24
<PAGE>

         Accounts Payable

Accounts payable were $1,014,566 at March 31, 2005, as compared to $1,104,392 at
December 31, 2004. This decrease is primarily attributed an improvement in cash
flow..

         Liquidity and Financing Arrangements

We have a history of substantial losses from operations and using rather than
providing cash in operations. We had an accumulated deficit of $19,001,330 and a
total stockholders' equity of $1,122,230 at March 31, 2005. As of March 31,
2005, our monthly operating costs and interest expenses averaged approximately
$368,000 per month.

Significant amounts of additional cash will be needed to reduce our debt and
fund our losses until such time as we are able to become profitable. At March
31, 2005, we were in default of notes payable whose principal amount was
approximately $23,000. In addition, the principal amount of notes that either
matured in 2004 or are payable on demand was approximately $2,276,000.

In conjunction with our efforts to improve our results of operations, discussed
above, we are also actively seeking infusions of capital from investors and are
seeking to replace our operating line of credit. It is unlikely that we will be
able, in our current financial condition, to obtain additional debt financing;
and if we did acquire more debt, we would have to devote additional cash flow to
paying the debt and securing the debt with assets. We may therefore have to rely
on equity financing to meet our anticipated capital needs. There can be no
assurances that we will be successful in obtaining such capital. If we issue
additional shares for debt and/or equity, this will dilute the value of our
common stock and existing shareholders' positions.

Subsequent to our acquisition of Circuit in July 2000, we took steps to increase
the marketability of our shares of common stock and to make an investment in our
company by potential investors more attractive. These efforts consisted
primarily of seeking to become current in our filings with the Securities and
Exchange Commission and of seeking approval for quotation of our stock on the
NASD Over the Counter Electronic Bulletin Board. NASD approval for quotation of
our stock on the Over the Counter Electronic Bulletin Board was obtained in July
2002.

Notes Payable to Equity Line Investor -- During 2003, we borrowed a total of
$1,830,000 from Cornell Capital Partners, LP, pursuant to nine unsecured
promissory notes. The loans were made and the notes were issued from June 2003
through December 2003. In lieu of interest, we paid fees to the lender, ranging
from 5% to 10%, of the amount of the loan. These fees have been recorded as
interest expense. The fees were negotiated in each instance and agreed upon by
us and by the lender and its affiliate. The notes were repayable over periods
ranging from 70 days to 131 days. Each of the notes stated that if we did not
repay the notes when due, a default interest rate of 24% would apply to the
unpaid balance. Through December 31, 2003, we directed the repayment of
$1,180,000 of these notes from proceeds generated under the Equity Line
Agreement, discussed in Note 10 below. At December 31, 2003, the balance owing
on these notes was $650,000. All notes were paid when due or before, and at no
time did we incur the 24% penalty interest rate.

During the year ended December 31, 2004, Cornell loaned us an additional
$3,200,000 pursuant to four additional unsecured promissory notes, $1,700,000 of
which remained outstanding at December 31, 2004. The loans were made and the
notes were issued in January through June 2004, bringing the total aggregate
loans from Cornell to $5,030,000. As before, in lieu of interest, we paid fees
to the lender, ranging from 4% to 5%, of the amount of the loan. The fees were
negotiated in each instance and agreed upon by us and by the lender and its
affiliate. The notes were repayable over periods of 88 days and 193 days. Each


                                       25
<PAGE>

of the notes stated that if we did not repay the notes when due, a default
interest rate of 24% would apply to the unpaid balance.

As noted above, we received proceeds of $5,030,000 from notes payable to
Cornell. We used the proceeds from these notes to fund operating losses of
approximately $2,938,000, pay down accounts payable, notes payable and other
settlements of approximately $1,401,000, purchase equipment and tooling in the
amount of $391,000, and to invest in Broadata in the amount of $300,000. During
January 2005, the Company received proceeds of $565,000 from an additional note
payable to Cornell to fund the settlement with the Internal Revenue Service. The
Company issued a note to repay by January 28, 2006.

There can be no assurance that we will be successful in obtaining more debt
and/or equity financing in the future or that our results of operations will
materially improve in either the short- or the long-term. If we fail to obtain
such financing and improve our results of operations, we will be unable to meet
our obligations as they become due. That would raise substantial doubt about our
ability to continue as a going concern.

Prior Equity Line of Credit Agreement

In conjunction with efforts to improve the results of our operations, discussed
above, on November 5, 2002, we entered into an Equity Line of Credit Agreement
with Cornell Capital Partners, LP, a private investor ("Cornell"). We
subsequently terminated that agreement, and on April 8, 2003, we entered into an
amended equity line agreement (the "Equity Line Agreement") with Cornell. Under
the Equity Line Agreement, we have the right to draw up to $5,000,000 from
Cornell against an equity line of credit (the "Equity Line"), and to put to
Cornell shares of our common stock in lieu of repayment of the draw. The number
of shares to be issued is determined by dividing the amount of the draw by the
lowest closing bid price of our common stock over the five trading days after
the advance notice is tendered. Cornell is required under the Equity Line
Agreement to tender the funds requested by us within two trading days after the
five-trading-day period used to determine the market price.

During the year ended December 31, 2004, we drew an aggregate amount of
$2,150,000 under the Equity Line Agreement, pursuant to draws on the Equity
Line, net of fees of $86,000, and issued a total of 57,464,386 shares of common
stock to Cornell under the Equity Line Agreement. At our direction, Cornell
retained the proceeds of the draws under the Equity Line Agreement and applied
them as payments on the notes to Cornell, discussed above.

Pursuant to the Equity Line Agreement, in connection with each draw, we agreed
to pay a fee of 4% of the amount of the draw to Cornell as consideration for its
providing the Equity Line. Total fees paid for the year ended December 31, 2004
were $128,000. Of these payments, $86,000 was offset against additional paid-in
capital as shares were issued under the Equity Line Agreement and $68,000 was
recorded as deferred offering costs for total deferred offering costs of $68,000
at December 31, 2004. These deferred offering costs will be offset against
additional paid-in capital as shares are issued under the Equity Line Agreement
subsequent to March 31, 2005.

Standby Equity Distribution Agreement

         We entered into a Standby Equity Distribution Agreement (the
"Agreement") dated May 21, 2004, with Cornell Capital Partners, LP (the "SEDA
Investor"). Under the Agreement, we have the right, at our sole discretion, to
sell periodically to the SEDA Investor shares of our common stock for an
aggregate purchase price of up to $20 million. The purchase price for the shares
sold to the SEDA Investor is equal to the lowest volume-weighted average price
of our common stock during the pricing period consisting of the five consecutive
trading days after we give an advance notice. The periodic sale of shares is
known as an advance. We may request an advance, by giving a written advance


                                       26
<PAGE>

notice to the SEDA Investor, and may not request advances more frequently than
every seven trading days. A closing will be held on the first trading day after
the end of the pricing period. The maximum advance amount is one million dollars
($1,000,000) per advance, with a minimum of seven trading days between advances.
In addition, we may not request advances if the shares to be issued in
connection with such advances would result in the SEDA Investors owning more
than 9.9% of our outstanding common stock.

         The SEDA Investor will retain a commitment fee of 5% of the amount of
each advance under the Agreement.

         Proceeds used under the Agreement will be used for general corporate
purposes and likely will include the repayment of notes issued to Cornell, the
SEDA Investor. We cannot predict the total amount of proceeds to be raised in
this transaction because we have not determined the total amount of the advances
we intend to draw.

         As noted above, we intend to use proceeds from the SEDA facility to
repay the outstanding balance of $1,700,000 owing to Cornell under a note
payable. Doing so will reduce the amount available to us for other corporate
purposes under the SEDA facility from $20,000,000 to $18,300,000. Management
believes that the remaining amount will be sufficient to sustain our operations
for the commitment period of the SEDA facility, which is 24 months from the date
a registration statement covering the resale of shares by the SEDA Investor is
declared effective. However, if we are able to obtain funding on better terms,
or if our operations begin to generate sufficient revenues to allow us to
operate without drawing on the SEDA facility or at reduced amounts, we may not
draw the full remaining $18,300,000 available to us. As discussed above, under
the Agreement we are not required to draw any of the amounts available to us
under the SEDA facility. Whether to draw and the extent to which we make draws
is in our discretion, and we will make draws only as needed.

Forward-looking statements

All statements made in this report, other than statements of historical fact,
which address activities, actions, goals, prospects, or new developments that we
expect or anticipate will or may occur in the future, including such things as
expansion and growth of operations and other such matters, are forward-looking
statements. Any one or a combination of factors could materially affect our
operations and financial condition. These factors include competitive pressures,
success or failure of marketing programs, changes in pricing and availability of
parts inventory, creditor actions, and conditions in the capital markets.
Forward-looking statements made by us are based on knowledge of our business and
the environment in which we currently operate. Because of the factors listed
above, as well as other factors beyond our control, actual results may differ
from those in the forward-looking statements.

Item 3.  Evaluation of Disclosure Controls and Procedures

Evaluation of Disclosure Controls and Procedures. Our Chief Executive Officer,
who is also our Chief Financial Officer, after evaluating the effectiveness of
the Company's "disclosure controls and procedures" (as defined in the Securities
Exchange Act of 1934 (Exchange Act) Rules 13a-15(e) or 15d-15(e)) as of the end
of the period covered by this annual report, has concluded that our disclosure
controls and procedures are effective based on their evaluation of these
controls and procedures required by paragraph (b) of Exchange Act Rules 13a-15
or 15d-15.

Changes in Internal Control Over Financial Reporting. There were no changes in
our internal control over financial reporting identified in connection with the
evaluation required by paragraph (d) of Exchange Act Rules 13a-15 or 15d-15 that
occurred during our last fiscal quarter that have materially affected, or are


                                       27
<PAGE>

reasonably likely to materially affect, our internal control over financial
reporting.

Section 404 Assessment. Section 404 of the Sarbanes-Oxley Act of 2002 requires
management's annual review and evaluation of our internal controls, and an
attestation of the effectiveness of these controls by our independent registered
public accountants beginning with our Form 10-K for the fiscal year ending on
December 31, 2007. We plan to dedicate significant resources, including
management time and effort, and to incur substantial costs in connection with
our Section 404 assessment. The evaluation of our internal controls will be
conducted under the direction of our senior management. We will continue to work
to improve our controls and procedures, and to educate and train our employees
on our existing controls and procedures in connection with our efforts to
maintain an effective controls infrastructure at our Company.

Limitations on Effectiveness of Controls. A system of controls, however well
designed and operated, can provide only reasonable, and not absolute, assurance
that the system will meet its objectives. The design of a control system is
based, in part, upon the benefits of the control system relative to its costs.
Control systems can be circumvented by the individual acts of some persons, by
collusion of two or more people, or by management override of the control. In
addition, over time, controls may become inadequate because of changes in
conditions, or the degree of compliance with the policies or procedures may
deteriorate. In addition, the design of any control system is based in part upon
assumptions about the likelihood of future events.

PART II. OTHER INFORMATION

Item 1.      Legal Proceedings

As of March 31, 2005, the Company had accrued liabilities in the amount of
$211,660 for delinquent payroll taxes, including interest and penalties due to
the State of Utah. In November 2003, the Company entered into an agreement with
the Utah State Tax Commission to allow the Company to pay the liability owing to
the State of Utah in equal monthly installments over a two year period. Under
the agreement, the Company would make monthly payments of $4,000 per month
through November 2005. As of May 20, 2005, the Company was current in its
payments to the State of Utah.

As of December 31, 2004, the Company had accrued liabilities in the amount of
$500,000 for delinquent payroll taxes, including interest and penalties, owed to
the Internal Revenue Service. The Company, in response to collection notices,
filed a due process appeal with the Internal Revenue Service's Appeals Office.
The appeal was resolved by an agreement with the Appeals Office that allowed the
Company to file an offer in compromise of all federal tax liabilities owed by
the Company based on its ability to pay. The Company filed its offer in
compromise with the IRS in November 2003, and after meeting with IRS personnel,
filed a revised offer in compromise on August 31, 2004. The Company was notified
in November 2004 that the IRS had accepted the offer in compromise. Under the
offer, the Company was required to pay an aggregate amount of $500,000
(representing payments of $350,000 by Circuit Technology, Inc., $100,000 by
CirTran Corporation, and $50,000 by Racore Technology, Inc.), not later than
February 3, 2005. These amounts were paid. Additionally, the Company must remain
current in its payment of taxes for 5 years, and may not claim any NOLs for the
years 2001 through 2015, or until the three companies pay taxes in an amount
equal to the taxes waived by the offer in compromise.

We (as successor to Circuit Technology, Inc.) were a defendant in an action in
El Paso County, Colorado District Court, brought by Sunborne XII, LLC, a
Colorado limited liability company, for alleged breach of a sublease agreement
involving facilities located in Colorado. Our liability in this action was
originally estimated to range up to $2.5 million, and we subsequently filed a
counter suit in the same court against Sunborne in an amount exceeding $500,000


                                       28
<PAGE>

for missing equipment. Effective January 18, 2002, we entered into a settlement
agreement with Sunborne with respect to the above-described litigation. The
settlement agreement required us to pay Sunborne the sum of $250,000. Of this
amount, $25,000 was paid upon execution of the agreement, and the balance of
$225,000, together with interest at 8% per annum, was payable by July 18, 2002.
As security for payment of the balance, we executed and delivered to Sunborne a
Confession of Judgment and also issued to Sunborne 3,000,000 shares of our
common stock, which were held in escrow and have been treated as treasury stock
recorded at no cost. Because 75% of the balance owing under the agreement was
not paid by May 18, 2002, we were required to prepare and file with the
Securities & Exchange Commission, at our expense, a registration statement with
respect to the shares that were escrowed. The payment was not made, nor was a
registration statement filed with respect to the escrowed shares.

Pursuant to a Termination of Sublease Agreement dated as of May 22, 2002 among
the Company, Sunborne and other parties, the sublease agreement that was the
subject of our litigation with Sunborne was terminated and a payment of
approximately $109,000 was credited against the amount owed by the Company to
Sunborne under the Company's settlement agreement with them. Sunborne has filed
a claim that this amount was to be an additional rent expense rather than a
payment on the note payable. The Company disputes this claim and intends to
vigorously defend the action.

As of April 8, 2005, the Company was in default of its obligations under the
settlement agreement with Sunborne, i.e., the total payment due thereunder had
not been made, a registration statement with respect to the escrowed shares was
not filed, and the Company did not replace the escrowed shares with registered,
free-trading shares as per the terms of the agreement. Accordingly, Sunborne has
filed the Confession of Judgment and proceeded with execution thereon.
Additionally, Sunborne sold the 3,000,000 shares. The Company is continuing to
negotiate with Sunborne in an attempt to settle the remaining obligation.

C/S Utilities notified the Company that it believes it has a claim against the
Company in the amount of $32,472 regarding utilities services. The claim was
assigned to BC Services, Inc., which obtained a judgment against Circuit
Technology, Inc., for $37,965.84 in El Paso County, Colorado, District Court on
February 13, 2003. The Company is reviewing its records in an effort to confirm
the validity of the claims and is evaluating its options.

We also assumed certain liabilities of Circuit Technology, Inc., in connection
with our transactions with that entity in the year 2000, and as a result we are
defendant in a number of legal actions involving nonpayment of vendors for goods
and services rendered. We have accrued these payables and have negotiated
settlements with respect to some of the liabilities, including those detailed
below, and are currently negotiating settlements with other vendors.

Howard Salamon, dba Salamon Brothers vs. CirTran Corporation, Civil No.
2:03-00787, U.S. District Court, District of Utah. Howard Salamon originally
filed suit against the Company in the U.S. District Court, Eastern District of
New York, seeking finders fees, consisting of shares of the Company's common
stock valued at $350,000, allegedly owed in connection with Salamon's
introducing the Company to Cornell Capital Partners, L.P., the Equity Line
Investor. The Company disputes the claims in the complaint. The case was
dismissed in New York and refiled in Utah. The Company has filed its answer in
the Utah case and the lawsuit is proceeding. The Plaintiff has sought leave to
file an amended complaint, which the court granted. The Company subsequently was
served with a supplemental complaint, in which Salamon seeks additional finders
fees, consisting of shares of the Company's common stock valued at $1,400,000
(for an aggregate claim of $1,750,000), to which the Company filed its answer.
The case is still in the discovery phase. The Company is also currently
conducting settlement negotiations.

RecovAR Group, LLC vs. CirTran Corporation, Inc., District Court of Maryland.


                                       29
<PAGE>

This matter arises from an agreement between the Company and United Parcel
Services, Inc. ("UPS"). UPS alleges that the Company owes approximately $8,024
for services rendered. RecovAR Group, LLC, brought the action on behalf of UPS.
The Company is continuing its settlement negotiations with RecovAR Group, LLC.

CirTran Asia v. Mindstorm Civil No. 050902290, Third Judicial District Court,
Salt Lake County, State of Utah. CirTran Asia brought suit against Mindstorm
Technologies, LLC, for nonpayment for goods provided. On April 22, 2005, the
defendant filed its answer and counterclaim. CirTran Asia is reviewing the
counterclaim and intends to vigorously pursue this action.

CirTran Asia, et al. v.  International  Edge, et al.,  Civil No. 2:05 CV 413BSJ,
U.S.  District  Court,  District of Utah. On May 11, 2005,  CirTran Asia,  UKING
System Industry Co., Ltd., and Charles Ho filed suit against International Edge,
Inc.,  Michael Casey  Enterprises,  Inc., Michael Casey, David Hayek, and HIPMG,
Inc., for breach of contract,  breach of the implied  covenant of good faith and
fair dealing, interference with economic relationships, and fraud in relation to
the  manufacture of the Ab King Pro.  CirTran Asia intends to vigorously  pursue
this action.

Item 5.  Other Information

Abacas Ventures

An explanation of the relationship between CirTran and Abacas Ventures, Inc., is
as follows:

Two trusts, the Saliba Living Trust and the Saliba Private Annuity Trust
(collectively, the "Saliba Trusts"), were investors in Circuit Technology, a
Utah corporation and predecessor entity of the Company. The trustees of the
trusts are Tom and Betty Saliba, and Tom Saliba, respectively. (Tom Saliba is
the nephew of the grandfather of Trevor Saliba, one of the directors of
CirTran.) In July 2000, CirTran Corporation merged with Circuit Technology.
Through that merger, the Saliba Trusts became shareholders of CirTran. The
Saliba Trusts are also two of the shareholders of an entity named Abacas
Ventures, Inc. ("Abacas"). At the time of the merger, CirTran was in default on
several of its obligations, including an obligation to Imperial Bank. The Saliba
Trusts, through Abacas, purchased the bank's claim against CirTran to protect
their investment in CirTran. Since that time, Abacas has continued to settle
debts of CirTran to improve Abacas's position and to take advantage of certain
discounts that creditors of CirTran offered to settle their claims. On two
occasions, the Abacas shareholders have agreed to convert outstanding debt owed
by CirTran to Abacas into shares of CirTran common stock (discussed below).
Abacas continues to work with the company to settle claims by creditors against
CirTran, and, on occasion, to provide funding. There can be no assurance that
Abacus will agree to convert its existing debt, or any debt it acquires in the
future, into shares of CirTran, or that conversions will occur at a price and on
terms that are favorable to CirTran. If Abacus and CirTran cannot agree on
acceptable conversion terms, Abacus may demand payment of some or all of the
debt. If CirTran does not have sufficient cash or credit facilities to pay the
amount then due and owing by CirTran to Abacus, Abacus may exercise its rights
as a senior secured lender and commence foreclosure or other proceedings against
the assets of CirTran. Such actions by Abacus could have a material adverse
effect upon CirTran and its ability to continue in business.

In January, 2002, the Company entered into an agreement with Abacas under which
the Company issued an aggregate of 19,987,853 shares of common stock to four of
Abacas's shareholders in exchange for cancellation by Abacas of an aggregate
amount of $1,499,090 in senior debt owed to the creditors by the Company. The
shares were issued with an exchange price of $0.075 per share, for the aggregate
amount of $1,500,000.

                                       30
<PAGE>

In December, 2002, the Company entered into an agreement with Abacas under which
the Company issued an aggregate of 30,000,000 shares of common stock to four of
Abacas's shareholders in exchange for cancellation by Abacas of an aggregate
amount of $1,500,000 in senior debt owed to the creditors by the Company. The
shares were issued with an exchange price of $0.05 per share, for the aggregate
amount of $1,500,000.

During 2002, the Company entered into a verbal bridge loan agreement with
Abacas. This agreement allows the Company to request funds from Abacas to
finance the build-up of inventory relating to specific sales. The loan bears
interest at 24% and is payable on demand. There are no required monthly
payments. During the years ended December 31, 2004 and 2003, the Company was
advanced $3,128,281 and $350,000, respectively, and made cash payments of
$3,025,149 and $875,000, respectively.

During the year ended December 31, 2004, Abacas completed negotiations with
several vendors of the Company, whereby Abacas purchased various past due
amounts for goods and services provided by vendors, as well as notes payable
(see Note 6). The total of these obligations was $1,263,713. The Company has
recorded this transaction as a $1,263,713 non-cash increase to the note payable
owed to Abacas, pursuant to the terms of the Abacas agreement.

The total principal amount owed to Abacas between the note payable and the
bridge loan was $1,530,587 and $163,742 as of December 31, 2004 and 2003,
respectively. The total accrued interest owed to Abacas between the note payable
and the bridge loan was $430,828 and $230,484 as of December 31, 2004 and 2003,
respectively, and is included in accrued liabilities. In March 2005, the
shareholders of Abacas agreed to cancel $2,050,000 of principal and accrued
interest in return for the Company's issuing 51,250,000 shares of our restricted
common stock to certain shareholders of Abacas. No registration rights were
granted.

As of December 31, 2001, Iehab Hawatmeh had loaned us a total of $1,390,125. The
loans were demand loans, bore interest at 10% per annum and were unsecured.
Effective January 14, 2002, we entered into four substantially identical
agreements with existing shareholders pursuant to which we issued an aggregate
of 43,321,186 shares of restricted common stock at a price of $0.075 per share
for $500,000 in cash and the cancellation of $2,749,090 principal amount of our
debt. Two of these agreements were with the Saliba Private Annuity Trust, one of
our principal shareholders, and a related entity, the Saliba Living Trust. The
Saliba trusts are also principals of Abacas Ventures, Inc., which entity
purchased our line of credit in May 2000. Pursuant to the Saliba agreements, the
trusts were issued a total of 26,654,520 shares of common stock in exchange for
$500,000 cash and the cancellation of $1,499,090 of debt. We used the $500,000
cash from the sale of the shares for working capital. As a result of this
transaction, the percentage of our common stock owned by the Saliba Private
Annuity Trust and the Saliba Living Trust increased from approximately 6.73% to
approximately 17.76%. Mr. Trevor Saliba, one of our directors and officers, is a
passive beneficiary of the Saliba Private Annuity Trust. Pursuant to the other
two agreements made in January 2002, we issued an aggregate of 16,666,666 shares
of restricted common stock at a price of $0.075 per share in exchange for the
cancellation of $1,250,000 of notes payable by two shareholders, Mr. Iehab
Hawatmeh (our president, a director and our principal shareholder) and Mr. Rajai
Hawatmeh. Of these shares, 15,333,333 were issued to Iehab Hawatmeh in exchange
for the cancellation of $1,150,000 in debt. As a result of this transaction, the
percentage of our common stock owned by Mr. Hawatmeh increased from 19.9% to
approximately 22.18%.

In February 2000, prior to its acquisition of Vermillion Ventures, Inc., a
public company, Circuit Technology, Inc., while still a private entity, redeemed
680,145 shares (as presently constituted) of common stock held by Raed Hawatmeh,
who was a director of Circuit Technology, Inc. at that time, in exchange for
$80,000 of expenses paid on behalf of the director. No other stated or unstated


                                       31
<PAGE>

rights, privileges, or agreements existed in conjunction with this redemption.
This transaction was consistent with other transactions where shares were
offered for cash.

In 1999, Circuit entered into an agreement with Cogent Capital Corp., or
"Cogent," a financial consulting firm, whereby Cogent agreed to assist and
provide consulting services to Circuit in connection with a possible merger or
acquisition. Pursuant to the terms of this agreement, we issued 800,000
(pre-forward split) restricted shares (12,000,000 post-forward split shares) of
our common stock to Cogent in July 2000 in connection with our acquisition of
the assets and certain liabilities of Circuit. The principal of Cogent was
appointed a director of Circuit after entering into the financial consulting
agreement and resigned as a director prior to the acquisition of Circuit by
Vermillion Ventures, Inc. on July 1, 2000.

Also, as of December 31, 2004 the company owed I&R Properties, LLC, the previous
owner of our principal office and manufacturing facility for unpaid accrued rent
and accrued interest. The Company settled with owed I&R Properties, LLC., on
accrued rent and interest of $400,000 by issuing 10,000,000 shares of
unregistered common stock in March 2005.

Management believed at the time of each of these transactions and continues to
believe that each of these transactions were as fair to the Company as could
have been made with unaffiliated third parties.

Purchase of Interests in Landlord

On March 31, 2005, the Company entered into a Membership Acquisition Agreement
(the "Acquisition Agreement") with Rajayee Sayegh (the "Seller") for the
purchase of one hundred percent (100%) of the membership interests in PFE
Properties LLC, a Utah limited liability company ("PFE"). Under the Acquisition
Agreement, the Company agreed to issue twenty million (20,000,000) shares of its
restricted common stock, with a fair value of $800,000 on the date of issuance.
No registration rights were granted. The shares were issued without registration
under the 1933 Act in reliance on Section 4(2) of the Securities Act of 1933, as
amended (the "1933 Act"), and the rules and regulations promulgated thereunder.

The primary asset of PFE is its rights, titles and interests in and to a parcel
of real property, together with any improvements, rents and profits thereon or
associated therewith, located at 4125 S. 6000 W., West Valley City, Utah, 84128,
where the Company presently has its headquarters and manufacturing facility.

Prior to the purchase of the membership interests, on December 17, 2003, the
Company had entered into a ten-year lease with PFE for the property. The lease
payments were $16,974. Following the acquisition of the PFE interests, PFE will
continue to own the building, and the Company will continue to make lease
payments under the 2003 lease.

Item 6.      Exhibits

         Exhibits:

         31       Certification
         32       Certification Pursuant to 18 U.S.C. Section 1350, as Adopted
                  Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002



                                       32
<PAGE>



                                   SIGNATURES

In accordance with the Securities Exchange Act of 1934, the registrant caused
this report to be signed on its behalf by the undersigned thereunto duly
authorized.


                                            CIRTRAN CORPORATION

Date:   May 20, 2005                By: /s/ Iehab J. Hawatmeh
                                        ---------------------------------------
                                        Iehab J. Hawatmeh
                                        President and Chief Financial Officer